Agyemang, E., Magaret, A. S., Selke, S., Johnston, C., Corey, L., & Wald, A. (2018). Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of Antivirals. J Infect Dis.

Agyemang, Elfriede, Amalia S. Magaret, Stacy Selke, Christine Johnston, Larry Corey, ja Anna Wald. "Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of Antivirals." J Infect Dis 2018.

Agyemang, Elfriede, et al. "Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of Antivirals." J Infect Dis 2018.